Skip to main content

Table 10 Baseline and other characteristics of the propensity score-matched patients receiving fondaparinux or enoxaparin (THA)

From: Venous thromboembolism after total joint arthroplasty: results from a Japanese multicenter cohort study

  Fondaparinux Enoxaparin P value
n = 144 n = 144
Gender, male/female 20/124 23/121 0.620
Age, years    
  Mean ± SD 67.3 ± 10.0 68.0 ± 8.8 0.707
  Range 40-87 44-86  
Body mass index, kg/m2    
  Mean ± SD 23.4 ± 3.8 23.8 ± 3.6 0.386
History of venous thrombosis, n (%) - -  
malignant tumor 5 (3.5%) 0 0.030
Comorbidities, n (%)    
  Hypertension 59 (41.0%) 54 (37.5%) 0.546
  Ischemic heart disease 7 (4.9%) 6 (4.2%) 0.777
  Diabetes 11 (7.6%) 10 (6.9%) 0.821
  Cerebrovascular disease 4 (2.8%) 3 (2.1%) 0.702
Operation time, minutes    
  Mean ± SD 124.6 ± 38.7 125.6 ± 47.3 0.931
Primary diseases, n (%)    
  Rheumatoid arthritis 9 (6.3%) 5 (3.5%) 0.273
  Osteoarthritis 129 (89.6%) 129 (89.6%) 1.000
  Others 6 (4.2%) 10 (6.9%) 0.303
General anesthesia 141 (97.9%) 141 (97.9%) 1.000
Use of elastic stocking, n (%) 131 (91.0%) 133 (92.4%) 0.670
Use of foot pump, n (%) 138 (95.8%) 137 (95.1%) 0.777
Use of cement, n (%) 23 (16.0%) 24 (16.7%) 0.873
e-GFR, mL/min per 1.73 m2    
  Mean ± SD 81.9 ± 20.0 78.6 ± 16.8 0.220
  Range 29.0-139.0 37.7-128.9  
Serum albumin, g/dL    
  Mean ± SD 4.0 ± 0.5 4.1 ± 0.4 0.001
  Range 2.4-5.0 2.6-5.1  
Platelet count, 104/μL    
  Mean ± SD 27.7 ± 7.6 26.0 ± 7.7 0.048
  1. Kruskal-Wallis rank test were performed on the means of continuous variables. For categorical variables, chi-squared tests were used. e-GFR, estimated glomerular filtrating ratio; SD, standard deviation; THA, total hip arthroplasty.